NR 565 Final Exam — Advanced Pharmacology
Fundamentals: Exam Questions with Correct
Answers (VerifiedAnswers) Plus Rationales
2026 Q&A Instant Download PDF
Question 1
A patient is prescribed a medication that is highly protein
bound. Which change is most likely to increase the
pharmacologically active portion of the drug?
A. Increased albumin binding
B. Decreased renal blood flow
C. Displacement from plasma protein binding sites
D. Increased gastrointestinal motility
Rationale: Only the unbound fraction of a medication is
generally available to distribute into tissues, undergo
metabolism, and exert pharmacologic effects. When a highly
protein-bound medication is displaced from albumin by another
substance, the free concentration can temporarily increase. This
may increase pharmacologic effects or toxicity, particularly with
medications that have a narrow therapeutic index. Clinical
significance depends on the drug's distribution, clearance, and
therapeutic window.
Question 2
,A medication has a narrow therapeutic index. Which approach
is most appropriate when initiating therapy?
A. Use the highest tolerated dose
B. Avoid laboratory monitoring
C. Double the dose if the initial response is inadequate
D. Use careful dosing and appropriate therapeutic monitoring
Rationale: Drugs with a narrow therapeutic index have a
relatively small difference between concentrations that produce
therapeutic effects and concentrations that cause toxicity.
Examples include digoxin, lithium, and certain anticonvulsants.
Careful dose selection, assessment of patient-specific factors,
monitoring for adverse effects, and therapeutic drug monitoring
when indicated help maintain drug concentrations within a safe
range.
Question 3
A patient with significantly reduced renal function is prescribed
a medication primarily eliminated by the kidneys. What is the
primary concern?
A. Increased gastrointestinal absorption
B. Drug accumulation and toxicity
C. Reduced protein binding only
D. Immediate hepatic failure
,Rationale: Reduced renal clearance can prolong the half-life of
medications that are primarily eliminated unchanged through
the kidneys or as active metabolites. Without appropriate dose
or interval adjustment, drug concentrations may progressively
increase. The prescriber should consider renal function, the
medication's clearance pathway, therapeutic index, and
available dosing recommendations.
Question 4
Which statement best describes pharmacodynamics?
A. How the kidneys eliminate medications
B. How medications are absorbed from the gastrointestinal tract
C. How a drug produces its effects in the body
D. How rapidly a medication reaches the bloodstream
Rationale: Pharmacodynamics concerns the biochemical and
physiologic effects of medications and their mechanisms of
action. It includes receptor interactions, dose-response
relationships, agonism and antagonism, and therapeutic and
adverse effects. Pharmacokinetics, in contrast, describes what
the body does to the drug through absorption, distribution,
metabolism, and excretion.
Question 5
, A patient taking a medication metabolized by CYP450 enzymes
begins taking a potent CYP450 inhibitor. What should the
clinician anticipate?
A. Faster elimination of the medication
B. Reduced medication concentration
C. Increased concentration of the affected medication
D. Complete prevention of drug absorption
Rationale: CYP450 inhibitors decrease the activity of specific
metabolic enzymes. If a patient's medication depends on that
pathway for metabolism, inhibition can decrease clearance and
increase serum concentrations. The resulting increase may
enhance therapeutic effects but can also increase adverse
effects or toxicity. The exact interaction depends on the specific
enzyme and medications involved.
Question 6
Which statement about CYP450 enzyme induction is correct?
A. It always increases serum concentrations of substrate
medications
B. It prevents hepatic metabolism
C. It can increase metabolism and decrease concentrations of
affected medications
D. It primarily decreases renal filtration
Fundamentals: Exam Questions with Correct
Answers (VerifiedAnswers) Plus Rationales
2026 Q&A Instant Download PDF
Question 1
A patient is prescribed a medication that is highly protein
bound. Which change is most likely to increase the
pharmacologically active portion of the drug?
A. Increased albumin binding
B. Decreased renal blood flow
C. Displacement from plasma protein binding sites
D. Increased gastrointestinal motility
Rationale: Only the unbound fraction of a medication is
generally available to distribute into tissues, undergo
metabolism, and exert pharmacologic effects. When a highly
protein-bound medication is displaced from albumin by another
substance, the free concentration can temporarily increase. This
may increase pharmacologic effects or toxicity, particularly with
medications that have a narrow therapeutic index. Clinical
significance depends on the drug's distribution, clearance, and
therapeutic window.
Question 2
,A medication has a narrow therapeutic index. Which approach
is most appropriate when initiating therapy?
A. Use the highest tolerated dose
B. Avoid laboratory monitoring
C. Double the dose if the initial response is inadequate
D. Use careful dosing and appropriate therapeutic monitoring
Rationale: Drugs with a narrow therapeutic index have a
relatively small difference between concentrations that produce
therapeutic effects and concentrations that cause toxicity.
Examples include digoxin, lithium, and certain anticonvulsants.
Careful dose selection, assessment of patient-specific factors,
monitoring for adverse effects, and therapeutic drug monitoring
when indicated help maintain drug concentrations within a safe
range.
Question 3
A patient with significantly reduced renal function is prescribed
a medication primarily eliminated by the kidneys. What is the
primary concern?
A. Increased gastrointestinal absorption
B. Drug accumulation and toxicity
C. Reduced protein binding only
D. Immediate hepatic failure
,Rationale: Reduced renal clearance can prolong the half-life of
medications that are primarily eliminated unchanged through
the kidneys or as active metabolites. Without appropriate dose
or interval adjustment, drug concentrations may progressively
increase. The prescriber should consider renal function, the
medication's clearance pathway, therapeutic index, and
available dosing recommendations.
Question 4
Which statement best describes pharmacodynamics?
A. How the kidneys eliminate medications
B. How medications are absorbed from the gastrointestinal tract
C. How a drug produces its effects in the body
D. How rapidly a medication reaches the bloodstream
Rationale: Pharmacodynamics concerns the biochemical and
physiologic effects of medications and their mechanisms of
action. It includes receptor interactions, dose-response
relationships, agonism and antagonism, and therapeutic and
adverse effects. Pharmacokinetics, in contrast, describes what
the body does to the drug through absorption, distribution,
metabolism, and excretion.
Question 5
, A patient taking a medication metabolized by CYP450 enzymes
begins taking a potent CYP450 inhibitor. What should the
clinician anticipate?
A. Faster elimination of the medication
B. Reduced medication concentration
C. Increased concentration of the affected medication
D. Complete prevention of drug absorption
Rationale: CYP450 inhibitors decrease the activity of specific
metabolic enzymes. If a patient's medication depends on that
pathway for metabolism, inhibition can decrease clearance and
increase serum concentrations. The resulting increase may
enhance therapeutic effects but can also increase adverse
effects or toxicity. The exact interaction depends on the specific
enzyme and medications involved.
Question 6
Which statement about CYP450 enzyme induction is correct?
A. It always increases serum concentrations of substrate
medications
B. It prevents hepatic metabolism
C. It can increase metabolism and decrease concentrations of
affected medications
D. It primarily decreases renal filtration
